Early Relapse is Associated with the High Serum Soluble Interleukin-2 Receptor Level after the Sixth Cycle of R-CHOP Chemotherapy in Patients with Advanced Diffuse Large B-Cell Lymphoma

MLA

Shin Lee, et al. “Early Relapse Is Associated with the High Serum Soluble Interleukin-2 Receptor Level after the Sixth Cycle of R-CHOP Chemotherapy in Patients with Advanced Diffuse Large B-Cell Lymphoma.” Annals of Oncology, vol. 23, Oct. 2012, p. xi143. EBSCOhost, https://doi.org/10.1016/s0923-7534(20)32429-7.

APA

Shin Lee, Kei Fujita, Yoshimasa Urasaki, Yasufumi Matsuda, Satoshi Ikegaya, Kazutaka Takagi, Shinji Kishi, Kazuhiro Ito, Hiromichi Iwasaki, Akira Yoshida, Mihoko Takai, Naoko Hosono, Takanori Ueda, & Takahiro Yamauchi. (2012). Early Relapse is Associated with the High Serum Soluble Interleukin-2 Receptor Level after the Sixth Cycle of R-CHOP Chemotherapy in Patients with Advanced Diffuse Large B-Cell Lymphoma. Annals of Oncology, 23, xi143. https://doi.org/10.1016/s0923-7534(20)32429-7

Chicago

Shin Lee, Kei Fujita, Yoshimasa Urasaki, Yasufumi Matsuda, Satoshi Ikegaya, Kazutaka Takagi, Shinji Kishi, et al. 2012. “Early Relapse Is Associated with the High Serum Soluble Interleukin-2 Receptor Level after the Sixth Cycle of R-CHOP Chemotherapy in Patients with Advanced Diffuse Large B-Cell Lymphoma.” Annals of Oncology 23 (October): xi143. doi:10.1016/s0923-7534(20)32429-7.